Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use
- Resource Type
- Review Article
- Source
- In
Journal of the Formosan Medical Association April 2023 122(4):299-308 - Subject
- Language
- ISSN
- 0929-6646